Table 5 Post-operative complications and outcomes

Any complications

7 ^{F, J, K, L, O, Aa, Ad}

(n = 544)

3

(n = 284)

Geiger, 2016

68.0%

36.4%

Zhang X, 2014

13 (16.46%)

14 (45.16%)

Kroll, 1992

4 (13%)

17 (44%)

Infection

3 ^{F, L, T}

(n = 209)

0

Recipient site infection

6 ^{B, D, O, S, T, X}

(n = 1292)

1

(n = 179)

Chepeha, 2004

2 (3%)

18 (17%)

Donor site infection

3 ^{B, D, S}

(n = 983)

0

Donor site morbidity

1 ^Q

(n = 202)

0

Fistula

11 ^{B, F, K, O, Q, S, R, T, V, X, Aa}

(n = 1777)

2

(n = 902)

Goyal, 2017

18 (3.1%)

17 (8.2%)

Geiger, 2016

22.0%

7.3%

Abscess

1 ^F

(n = 105)

0

Dehiscence recipient or donor site

4 ^{F, K, S, V}

(n = 332)

1

(n = 105)

Geiger, 2016

44.0%

23.6%

Dehiscence recipient site

5 ^{D, L, O, V, X}

(n = 409)

1

(n = 179)

Chepeha, 2004

0

11 (10%)

Dehiscence donor site

8 ^{D, I, L, O, V, K, L, R} (n = 370)

0

Hematoma

2 ^{X, S}

(n = 293)

0

Hematoma Donor site

2 ^{E, V}

(n = 95)

0

Hematoma recipient site

2 ^{O, V}

(n = 124)

0

Partial flap necrosis

6 ^{I, O, V, X, Aa, Ad}

(n = 526)

1

(n = 179)

Chepeha, 2004

2 (2.82%)^#

12 (11%)^#

Total flap necrosis

2 ^{V, Aa}

(n = 181)

0

Partial or total flap necrosis

1 ^T

(n = 70)

1

(n = 70)

Mallet, 2009

1 (4%)

14 (31%)

Osteonecrosis

2^{B, F}

(n = 902)

1

(n = 105)

Geiger, 2016

24.0%

3.6%

Deep Vein Thrombosis (Inferious member)

2 ^{A, S}

(n = 631)

0

Venous obstruction (At site)

1 ^O

(n = 60)

0

Late anastomotic stricture

1^Q

(n = 202)

0

Operative revision surgery

8 ^{E, F, L, O, S, R, X, Aa} (n = 660)

2 (n = 136)

Howard, 2016

1.6 (1–3)

0.6 (0–1)

Geiger, 2016

34%

9.1%

Flap failure

8 ^{E, I, K, L, O, T, U, V} (n = 425)

1 (n = 70)

Mallet, 2009

1 (4%)

14 (31%)

Mortality at 30 days

2 (n = 228)^{K, X}

Mortality at 1-year

2 (n = 76)^{L, Y}

Mortality at 2-year

1 (n = 80)^U